Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 4, 2014

View Archived Issues

Amniox Medical initiates clinical trial of placenta-derived diabetic foot ulcer therapy

Lion Biotechnologies enters into trial agreement with Moffitt Cancer Center

Dong Wha completes phase III study of zabofloxacin in patients with COPD

Kalydeco approved in Europe in CF for eight non-G551D gating mutations

FUJIFILM presents novel PI3K and ERK-2 inhibitors

Researchers at Xencor divulge new heterodimeric proteins

Cubist Pharmaceuticals discloses novel TRPA1 antagonists

Novel HCV NS5A inhibitors disclosed by Merck & Co.

Daiichi Sankyo recaps pipeline progress of first quarter of fiscal 2014

Janssen Pharmaceutica patents novel gamma-secretase modulators

Kyowa Hakko Kirin seeks approval in Japan for KW-3357

Esteve confirms initiation of natural history study for Sanfilippo A syndrome

OncoCyte expands clinical development of bladder cancer diagnostic

First-in-human and in vitro results presented on novel drug for pre-transplantation desensitization

AFFiRiS reports results from phase I trial of Affitope PD-01A

Chugai Pharmaceuticals reports progress during second quarter 2014

Regeneron and Sanofi to use priority review voucher for alirocumab BLA

Shionogi to sell Ezose Sciences to Sumitomo Bakelite

Cara Therapeutics initiates abuse potential trial for CR-845

FDA approves olodaterol for COPD

Cortice Biosciences to develop heart failure drug for cognitive impairment

CHBP and caspase-3 siRNAs for renoprotection against ischemia reperfusion and CsA nephrotoxicity

Solasia gains exclusive worldwide rights to darinaparsin from Ziopharm Oncology

Alexion's eculizumab obtains European orphan drug designation for myasthenia gravis

Phase III trial initiated by Isis Pharmaceuticals for ISIS-SMNRx in infants

FDA approves empagliflozin for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...